title: The renal monoamine oxidases: pathophysiology and targets for therapeutic intervention.
abstract: The mitochondrial enzyme monoamine oxidases A and B are among the major metabolic agents for the degradation of the biogenic amines adrenaline, noradrenaline, dopamine and serotonin. The fact that the kidney contains a large amount of monoamine oxidase suggests that the renal effects of biogenic amines might depend in part on the activity of these enzymes.
authors.affiliation: INSERM U388, Department of Renal Molecular Pharmacology and Physiology, University Hospital Centre, Rangueil, Toulouse, France.
authors.forename: N
authors.initials: N
authors.lastname: Pizzinat
authors.forename: A
authors.initials: A
authors.lastname: Remaury
authors.forename: A
authors.initials: A
authors.lastname: Parini
mesh_terms: D000818:Animals; D006801:Humans; D007668:Kidney / Q000201:enzymology*; D007674:Kidney Diseases / Q000201:enzymology* / Q000503:physiopathology* / Q000628:therapy; D008995:Monoamine Oxidase / Q000096:biosynthesis / Q000378:metabolism*
chemical_list: D008995:Monoamine Oxidase